Literature DB >> 34583058

Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza A virus induce potent humoral and T-cell responses and protect against the viral infection.

Anna A Zykova1, Elena A Blokhina1, Liudmila A Stepanova2, Marina A Shuklina2, Liudmila M Tsybalova2, Victor V Kuprianov1, Nikolai V Ravin3.   

Abstract

The extracellular domain of the M2 protein (M2e) and conserved region of the second subunit of the hemagglutinin (HA2) could be used for the development of broad-spectrum vaccines against influenza A. Here we obtained and characterized recombinant mosaic proteins containing tandem copies of M2e and HA2 fused to an artificial self-assembling peptide (SAP). The inclusion of SAP peptides in the fusion proteins enabled their self-assembly in vitro into spherical particles with a size of 30-50 nm. Intranasal immunization of mice with these particles without additional adjuvants induced strong humoral immune response against M2e and the whole virus. Particles carrying both M2e and HA2 induced antigen-specific multifunctional CD4+ effector memory T cells. Immunization provided high protection of mice against the lethal challenge with different subtypes of influenza A virus. The obtained self-assembling nanoparticles can be used to develop a universal influenza vaccine.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hemagglutinin; Influenza; M2e peptide; Nanoparticle; Recombinant vaccine

Mesh:

Substances:

Year:  2021        PMID: 34583058     DOI: 10.1016/j.nano.2021.102463

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

1.  Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine.

Authors:  Ning Luan; Han Cao; Yunfei Wang; Kangyang Lin; Cunbao Liu
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

2.  A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice.

Authors:  Yongbo Qiao; YaXin Zhang; Jie Chen; Shenghui Jin; Yaming Shan
Journal:  Nano Res       Date:  2022-07-01       Impact factor: 10.269

3.  Comprehending B-Cell Epitope Prediction to Develop Vaccines and Immunodiagnostics.

Authors:  Salvador Eugenio C Caoili
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

Review 4.  Progress towards the Development of a Universal Influenza Vaccine.

Authors:  Wen-Chien Wang; Ekramy E Sayedahmed; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Viruses       Date:  2022-07-30       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.